GlassScriptPhysician profile
Eric David Cohen
NPI 1720065188
$2,249.44
in general payments reported to CMS, 2019-2025
28 companies · $50.98 in 2025
The $50.98 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $117 · 2021: $286 · 2022: $253 · 2023: $332 · 2024: $294 · 2025: $50.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.26 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $317.36 | 2019 | |
| Abiomed | $233.79 | 2021-2025 | Impella |
| Medtronic, INC. | $202.17 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $180.03 | 2019-2025 | |
| Amgen INC. | $146.41 | 2019-2023 | |
| Philips North America LLC | $136.49 | 2019-2024 | (5091) Amb Mon & Diag Und |
| Amarin Pharma, INC. | $116.18 | 2019-2021 | |
| Boston Scientific Corporation | $112.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $109.14 | 2019-2023 | Xarelto |
| Inspiremd LTD | $103.00 | 2024 | Cguard |
| Surmodics, INC. | $102.98 | 2023 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.59 | 2020-2021 | |
| Pfizer INC. | $57.76 | 2019-2020 | |
| Shockwave Medical, INC | $51.03 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $47.57 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $45.35 | 2020 | |
| Angiodynamics, INC. | $25.77 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.06 | 2019 | |
| Novo Nordisk INC | $25.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.94 | 2019 | |
| Glaxosmithkline, LLC. | $22.05 | 2022 | |
| Cordis US Corp. | $20.35 | 2024 | S.M.A.R.T. Control |
| Cvrx, INC. | $15.41 | 2023 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $13.49 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.10 | 2021 | |
| Lilly USA, LLC | $12.49 | 2021 | |
| Medtronic Vascular, INC. | $11.11 | 2019 | |
| Chiesi USA, INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.